Definitive Healthcare (DH) Stock Price, News & Analysis

Company Overview

Definitive Healthcare Corp. (NASDAQ: DH) provides commercial intelligence and data analytics solutions for the healthcare industry. Its platform is designed to help organizations identify and understand healthcare providers, institutions, markets and patient populations, supporting decisions related to sales, marketing, market access, strategy and business development.

The company’s products and services include healthcare provider and facility data, claims-based insights, organizational and affiliation information, analytics tools, workflow solutions and intelligence related to clinical trials and healthcare markets. Its customers include pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, health plans and other organizations that need information to plan and execute commercial activities.

Founded in 2011 and headquartered in Massachusetts, Definitive Healthcare primarily focuses on the United States healthcare market. The company became publicly traded on the Nasdaq in 2021. Its offerings combine proprietary healthcare data with software and analytical tools intended to help customers understand market dynamics, find relevant decision-makers and improve engagement across the healthcare ecosystem.

Key Stats

• Today's Range: $0.91 to $0.94
• 50-Day Range: $0.64 to $1.05
• 52-Week Range: $0.61 to $4.02
• Volume: 2.39 million shs
• Average Volume: 1.23 million shs
• Market Capitalization: $97.36 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $1.47
• Consensus Rating: Reduce

Definitive Healthcare Stock Analysis - MarketRank™

Definitive Healthcare scored higher than 69% of companies evaluated by MarketBeat, and ranked 227th out of 891 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Reduce

Consensus Rating

Definitive Healthcare has received a consensus rating of Reduce. The company's average rating score is 1.90, and is based on 1 strong buy rating, no buy ratings, 6 hold ratings, and 3 sell ratings.

Upside Potential

Definitive Healthcare has a consensus price target of $1.47, representing about 61.3% upside from its current price of $0.91.

Amount of Analyst Coverage

Definitive Healthcare has only been the subject of 4 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: -33.33%

Earnings Growth

Earnings for Definitive Healthcare are expected to decrease by -33.33% in the coming year, from $0.06 to $0.04 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Definitive Healthcare is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Definitive Healthcare is -0.57, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Definitive Healthcare has a PEG Ratio of 11.30. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Definitive Healthcare has a P/B Ratio of 0.34. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.06% of the float of Definitive Healthcare has been sold short.

Short Interest Ratio / Days to Cover

Definitive Healthcare has a short interest ratio ("days to cover") of 1.32, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Definitive Healthcare has recently decreased by 8.33%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Definitive Healthcare does not currently pay a dividend.

Dividend Growth

Definitive Healthcare does not have a long track record of dividend growth.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 0.45

News Sentiment

Definitive Healthcare has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.73 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Definitive Healthcare this week, compared to 2 articles on an average week.

Company Ownership

• Score: 1.3 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Definitive Healthcare insiders have not sold or bought any company stock.

Percentage Held by Insiders

17.09% of the stock of Definitive Healthcare is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

98.67% of the stock of Definitive Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 8/10/2026
• Today: 9/30/2026
• Next Earnings (Estimated): 11/05/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Technology
• Sub-Industry: Healthcare Technology
• Current Symbol: NASDAQ:DH
• CIK: 1861795
• Web: www.definitivehc.com
• Phone: 508-720-4224
• Fax: N/A
• Employees: 686
• Year Founded: 2011

Price Target and Rating

• Average Price Target for Definitive Healthcare: $1.47
• High Price Target: $3.00
• Low Price Target: $0.70
• Potential Upside/Downside: +61.3%
• Consensus Rating: Reduce
• Rating Score (0-4): 1.90
• Research Coverage: 10 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.60)
• Trailing P/E Ratio: 23.25
• Forward P/E Ratio: 15.20
• P/E Growth: 11.48
• Net Income: -$138.93 million
• Net Margins: -72.28%
• Pretax Margin: -102.30%
• Return on Equity: 3.55%
• Return on Assets: 1.63%

Debt

• Debt-to-Equity Ratio: 0.81
• Current Ratio: 1.86
• Quick Ratio: 1.86

Sales & Book Value

• Annual Sales: $241.52 million
• Price / Sales: 0.40
• Cash Flow: $1.94 per share
• Price / Cash Flow: 0.47
• Book Value: $2.66 per share
• Price / Book: 0.34

Miscellaneous

• Outstanding Shares: 106,750,000
• Free Float: 88,502,000
• Market Cap: $97.36 million
• Optionable: Not Optionable
• Beta: 1.40